Literature DB >> 20725151

LEM-PCR: a method for determining relative transcript isoform proportions using real-time PCR without a standard curve.

S Virtue1, M Dale, J K Sethi, A Vidal-Puig.   

Abstract

Many genes express multiple transcript isoforms generated by alternative splicing of mRNA. Using real-time PCR, it is straightforward to determine the relative expression level of each isoform independently. However, it is less trivial to determine the relative proportions of different isoforms in a cDNA sample. The relative proportions of different isoforms can be important, as a small change in a highly abundant transcript may be more relevant than a large change in a minimally expressed transcript. Currently, determining the relative proportions of isoforms requires the construction of a standard curve using recombinant plasmid DNA or genomic DNA. As recombinant or genomic DNA standards often amplify with different efficiencies to cDNA samples, they may give under- or overestimations of isoform abundances. The method described in this article uses a titration curve generated from the same cDNA samples measured in the experiment. By using samples with different levels of separate isoforms, it is possible to derive linear equations which, when solved, allow the determination of the proportion of each isoform within the samples under study.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20725151      PMCID: PMC4289856          DOI: 10.1139/g10-036

Source DB:  PubMed          Journal:  Genome        ISSN: 0831-2796            Impact factor:   2.166


  7 in total

Review 1.  Adipogenesis: forces that tip the scales.

Authors:  Ormond A MacDougald; Susanne Mandrup
Journal:  Trends Endocrinol Metab       Date:  2002 Jan-Feb       Impact factor: 12.015

2.  Rapid cycle DNA amplification: time and temperature optimization.

Authors:  C T Wittwer; D J Garling
Journal:  Biotechniques       Date:  1991-01       Impact factor: 1.993

3.  Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification.

Authors:  T B Morrison; J J Weis; C T Wittwer
Journal:  Biotechniques       Date:  1998-06       Impact factor: 1.993

4.  Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms.

Authors:  Y Zhu; C Qi; J R Korenberg; X N Chen; D Noya; M S Rao; J K Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

5.  mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.

Authors:  P Tontonoz; E Hu; R A Graves; A I Budavari; B M Spiegelman
Journal:  Genes Dev       Date:  1994-05-15       Impact factor: 11.361

6.  Regulation of insulin receptor substrate 1 pleckstrin homology domain by protein kinase C: role of serine 24 phosphorylation.

Authors:  Ranmali Nawaratne; Alexander Gray; Christina H Jørgensen; C Peter Downes; Kenneth Siddle; Jaswinder K Sethi
Journal:  Mol Endocrinol       Date:  2006-03-30

7.  A standard curve based method for relative real time PCR data processing.

Authors:  Alexey Larionov; Andreas Krause; William Miller
Journal:  BMC Bioinformatics       Date:  2005-03-21       Impact factor: 3.169

  7 in total
  2 in total

1.  Alternative splicing of ceramide synthase 2 alters levels of specific ceramides and modulates cancer cell proliferation and migration in Luminal B breast cancer subtype.

Authors:  Trishna Pani; Kajal Rajput; Animesh Kar; Harsh Sharma; Rituparna Basak; Nihal Medatwal; Sandhini Saha; Gagan Dev; Sharwan Kumar; Siddhi Gupta; Arnab Mukhopadhyay; Dipankar Malakar; Tushar Kanti Maiti; Aneeshkumar G Arimbasseri; S V S Deo; Ravi Datta Sharma; Avinash Bajaj; Ujjaini Dasgupta
Journal:  Cell Death Dis       Date:  2021-02-10       Impact factor: 8.469

2.  A reliable method for quantification of splice variants using RT-qPCR.

Authors:  Julia Camacho Londoño; Stephan E Philipp
Journal:  BMC Mol Biol       Date:  2016-03-15       Impact factor: 2.946

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.